Wed, October 24, 2018
Tue, October 23, 2018
Mon, October 22, 2018
Fri, October 19, 2018
Thu, October 18, 2018
Wed, October 17, 2018
Tue, October 16, 2018
Mon, October 15, 2018
Fri, October 12, 2018
Thu, October 11, 2018
Wed, October 10, 2018
Tue, October 9, 2018

Joel Beatty Maintained (VNDA) at Strong Buy with Increased Target to $31 on, Oct 16th, 2018


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-31-on-oct-16th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Joel Beatty of Citigroup, Maintained "Vanda Pharmaceuticals Inc." (VNDA) at Strong Buy with Increased Target from $27 to $31 on, Oct 16th, 2018.

Joel has made no other calls on VNDA in the last 4 months.



There are 2 other peers that have a rating on VNDA. Out of the 2 peers that are also analyzing VNDA, 1 agrees with Joel's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Charles Duncan of "Cantor Fitzgerald" Initiated at Hold and Held Target at $26 on, Thursday, August 23rd, 2018


This is the rating of the analyst that currently disagrees with Joel


  • Derek Archila of "Oppenheimer" Maintained at Buy with Increased Target to $29 on, Friday, September 21st, 2018

Publication Contributing Sources